Tag: Excellence in Neuroscience Award

Jolanta Dorszewska | Neuroscience | Research Excellence Award

Published on by World Science Awards

Research Excellence Award

Jolanta Dorszewska
Affiliation Poznan University of Medical Sciences
Country Poland
Scopus ID 6602690865
Documents 107
Citations 2,378
h-index 30
Subject Area Neuroscience
Event World Science Awards
ORCID 0000-0002-8241-0403

Jolanta Dorszewska
Poznan University of Medical Sciences

Jolanta Dorszewska is a Polish neuroscientist affiliated with Poznan University of Medical Sciences whose academic work focuses on the molecular mechanisms underlying neurodegenerative disorders, biomarkers, genetics, and translational neuroscience. Her publication record demonstrates sustained contributions to understanding neurological diseases through multidisciplinary biomedical research. The combination of extensive scholarly output, significant citation performance, and international visibility reflects an established research profile within contemporary neuroscience.[1] [2]

Abstract

This article presents an academic overview of Jolanta Dorszewska’s research achievements in neuroscience. Her scholarly activities emphasize molecular biology, neurodegenerative disease mechanisms, genetic biomarkers, oxidative stress, and clinical translation. Through peer-reviewed publications and collaborative investigations, her work has contributed to improved scientific understanding of neurological disorders while supporting advances in diagnostic and therapeutic research. The available bibliometric indicators demonstrate consistent scholarly influence and sustained academic productivity.[1] [3]

Keywords

Neuroscience, Neurodegenerative Diseases, Alzheimer’s Disease, Parkinson’s Disease, Molecular Biomarkers, Genetics, Oxidative Stress, Clinical Neuroscience, Translational Medicine, Neurobiology.

Introduction

Modern neuroscience increasingly relies on multidisciplinary research integrating molecular biology, genetics, pathology, and clinical medicine. Researchers investigating neurodegenerative disorders contribute to the identification of disease mechanisms, biomarkers, and therapeutic targets. Within this scientific landscape, Jolanta Dorszewska has developed an academic portfolio centered on understanding neurological disorders through laboratory and translational research approaches.[2] [4]

Research Profile

Affiliated with Poznan University of Medical Sciences in Poland, Jolanta Dorszewska has established a substantial publication record indexed in Scopus. Her documented scholarly metrics include more than one hundred indexed publications, over two thousand citations, and an h-index of 30, reflecting sustained influence within neuroscience research. Her investigations frequently examine neurodegenerative diseases, oxidative stress, genetic susceptibility, mitochondrial dysfunction, and molecular biomarkers relevant to neurological diagnosis and prognosis.[1] [3]

Research Contributions

Her research contributions encompass the molecular characterization of neurodegenerative disorders, evaluation of oxidative stress pathways, investigation of genetic polymorphisms, biomarker discovery, and translational neuroscience. These studies have contributed to improved scientific knowledge regarding Alzheimer’s disease, Parkinson’s disease, and related neurological conditions. The interdisciplinary nature of her work combines laboratory investigations with clinically relevant applications that support ongoing biomedical research.[3] [5]

Publications

The researcher’s publication portfolio includes peer-reviewed journal articles addressing molecular neuroscience, neurobiology, neurochemistry, biomarker research, and clinical neurology. Many publications examine biological mechanisms involved in neurodegeneration while exploring potential diagnostic indicators and therapeutic perspectives. The body of work has been disseminated through internationally recognized scientific journals indexed by major academic databases.[3] [5]

Research Impact

Bibliometric indicators suggest that Jolanta Dorszewska’s research has achieved notable academic visibility within neuroscience. Her publications have accumulated thousands of citations from the international scientific community, demonstrating continued relevance in studies concerning neurodegenerative disease mechanisms and translational biomedical research. Citation metrics should be interpreted as indicators of scholarly influence rather than sole measures of scientific quality.[1] [4]

Award Suitability

Based on publicly available academic information, Jolanta Dorszewska demonstrates characteristics commonly considered during evaluations for research excellence recognition. These include sustained scholarly productivity, measurable citation impact, specialization in neuroscience, contributions to biomedical knowledge, and continued engagement in internationally indexed research. Eligibility for any specific award remains subject to the formal assessment procedures and selection criteria established by the organizing committee.[1] [6]

Conclusion

Jolanta Dorszewska’s academic profile reflects a sustained commitment to neuroscience research, particularly in the study of neurodegenerative diseases and molecular medicine. Her publication record, citation performance, and continued scientific contributions illustrate an established research career dedicated to advancing biomedical knowledge through rigorous investigation and scholarly collaboration.[1] [3]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Jolanta Dorszewska, Author ID 6602690865. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602690865
  2. ORCID. (n.d.). Jolanta Dorszewska – ORCID Record.
    https://orcid.org/0000-0002-8241-0403
  3. Dorszewska, J., et al. Representative neuroscience publication discussing molecular mechanisms of neurodegeneration.
    DOI: https://doi.org/10.1016/j.neuint.2019.104512
  4. National Library of Medicine. (n.d.). PubMed indexed publications related to neuroscience and neurodegenerative diseases.
    https://pubmed.ncbi.nlm.nih.gov/
  5. Crossref. (n.d.). DOI Registration Agency.
    https://www.crossref.org/
  6. World Science Awards. (n.d.). Award information and nomination guidelines.

Claude Mekies | Neuroscience | Academic Research Impact Award

Published on by World Science Awards

Academic Research Impact Award

Claude Mekies
Affiliation Maison Médicale du Parc & Clinique des Cèdres
Country France
Scopus ID 8245716600
Documents 30
Citations 673
h-index 11
Subject Area Neurology, Neuro-ophthalmology, Multiple Sclerosis, Neurodegenerative Diseases
Event World Science Awards

Claude Mekies is a distinguished French neurologist, neuro-ophthalmology specialist, healthcare leader, and advocate for neurological education and patient-centered care. Over several decades, he has contributed extensively to clinical neurology, neurovascular medicine, multiple sclerosis management, epilepsy care, neurodegenerative disease policy, and therapeutic education. His leadership roles within national and international neurological organizations, combined with his clinical expertise and participation in public health initiatives, have established him as a significant contributor to neurological sciences in France and Europe.[1]

Abstract

Claude Raphaël Mekies has built a notable career in neurology through clinical practice, medical leadership, policy engagement, education, and research collaboration. His contributions span stroke management, multiple sclerosis, epilepsy, neuro-ophthalmology, therapeutic patient education, and neurodegenerative disease programs. As former President of the French Federation of Neurology and leader of multiple neurological organizations, he has played a strategic role in improving neurological care pathways, healthcare policies, and professional education initiatives throughout France.[2]

Keywords

Neurology, Multiple Sclerosis, Neurodegenerative Diseases, Neuro-ophthalmology, Epilepsy, Stroke Medicine, Therapeutic Education, Clinical Neurology, Healthcare Leadership, Public Health Policy, Alzheimer’s Disease, Neurovascular Medicine.

Introduction

Born in Rabat, Morocco, on 31 October 1960, Claude Raphaël Mekies completed his medical studies at the University of Toulouse-Purpan and subsequently specialized in neurology. His doctoral thesis on acute cerebral infarction thrombolysis received a Gold Medal distinction, reflecting early academic excellence. Since establishing private neurological practice in 1991, he has combined clinical service with extensive contributions to scientific societies, neurological networks, healthcare reform, and continuing medical education.[3]

Research Profile

Dr. Mekies possesses expertise across several neurological domains, including multiple sclerosis, epilepsy, stroke, neurodegenerative disorders, and neuro-ophthalmology. He earned a Diploma in Neuro-ophthalmology from Université Pierre et Marie Curie (Paris VI) in 2003 and has participated in clinical research involving functional MRI assessment of lesion recovery in multiple sclerosis. His engagement with clinical investigation centers and multidisciplinary neurological programs has strengthened translational approaches to neurological care.[4]

  • Neurology and neurovascular medicine.
  • Multiple sclerosis and neuroimmunology.
  • Epilepsy management and education.
  • Neuro-ophthalmology.
  • Neurodegenerative disease policy development.
  • Patient therapeutic education and healthcare innovation.

Research Contributions

Among his most influential contributions is the co-founding of the Midi-Pyrénées Multiple Sclerosis Network (MIPSEP), which facilitated coordinated care pathways for patients with multiple sclerosis. He also participated in the creation of a Neurovascular Intensive Care Unit at Clinique des Cèdres and contributed to national recommendations concerning stroke management, transient ischemic attack diagnosis, multiple sclerosis care, vaccination strategies, pregnancy-related neurological management, and neurodegenerative disease frameworks.[5]

  • Co-founder of MIPSEP neurological care network.
  • Contributor to national stroke and Alzheimer disease programs.
  • Participant in clinical neuroimaging and neurological rehabilitation studies.
  • Developer of educational tools for neurologists and healthcare professionals.
  • Contributor to multiple sclerosis and NMOSD clinical recommendations.

Publications

Dr. Mekies maintains an indexed scholarly presence through Scopus Author ID 8245716600. His scientific activities encompass peer-reviewed publications, conference proceedings, neurological education resources, consensus documents, and contributions to clinical guidelines. His work reflects a sustained focus on evidence-based neurological practice and multidisciplinary patient care.[1]

Research Impact

The impact of Dr. Mekies extends beyond traditional academic publication metrics. His influence is evident through leadership positions within the French Federation of Neurology, the Association des Neurologues de Langue Française, the Ligue Française contre la Sclérose en Plaques, and European neurological initiatives. His contributions have supported improved patient access to care, enhanced professional education, and strengthened neurological healthcare policies at regional and national levels.[2]

Award Suitability

Claude Raphaël Mekies demonstrates strong suitability for international recognition in neurology and neurodegenerative disease leadership. His qualifications include distinguished clinical practice, sustained professional service, scientific contributions, policy engagement, healthcare innovation, and educational leadership. His appointment as Chevalier de la Légion d’Honneur in 2016 further reflects the national significance of his contributions to healthcare and society.[3]

Conclusion

Through a career spanning clinical neurology, scientific leadership, healthcare policy, and patient advocacy, Claude Raphaël Mekies has contributed substantially to the advancement of neurological medicine. His work in multiple sclerosis, neurodegenerative disorders, stroke care, epilepsy, and professional education demonstrates a sustained commitment to improving patient outcomes and strengthening neurological healthcare systems. These achievements support his recognition within prestigious international academic and professional award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Claude Raphaël Mekies, Author ID 8245716600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=8245716600
  2. French Neurological Organizations and Professional Leadership Records. Documentation relating to neurological society governance, multiple sclerosis initiatives, and neurodegenerative disease programs.
  3. Professional Curriculum Vitae of Claude Raphaël Mekies, including medical education, neurological specialization, leadership appointments, and national honors.
  4. Université Pierre et Marie Curie (Paris VI). Diploma in Neuro-ophthalmology and related specialist training records.
  5. French Society and Government Neurological Recommendations. Stroke, Alzheimer’s disease, multiple sclerosis, NMOSD, vaccination, and neurodegenerative disease guideline contributions.

Yashar Sarbaz | Neuroscience | Best Researcher Award

Published on by World Science Awards

Assoc. Prof. Dr. Yashar Sarbaz | Neuroscience | Best Researcher Award

Full-Time Faculty, ECE department at University of Tabriz, Iran

Dr. Yashar Sarbaz is a distinguished Iranian researcher specializing in biomedical engineering, with a focus on neurodegenerative disease modeling. Born on May 20, 1981, in Tabriz, Iran, he has consistently demonstrated academic excellence and a profound commitment to advancing medical science through interdisciplinary approaches. Dr. Sarbaz’s work integrates bioelectric engineering, control systems, and computational neuroscience, aiming to develop innovative solutions for complex neurological disorders. His extensive research has significantly contributed to the understanding and potential treatment of diseases such as Parkinson’s and Huntington’s.

Professional Profile

Education

Dr. Sarbaz’s academic journey commenced at the University of Tabriz, where he earned his Bachelor of Science in Electronic Engineering in 2002, graduating at the top of his class with a GPA of 17.44/20. He then pursued a Master of Science in Control Engineering at Sharif University of Technology, completing his degree in 2004 with a GPA of 18.19/20 and again ranking first in his class. His master’s thesis focused on modeling Parkinson’s disease and its treatment. In 2011, Dr. Sarbaz obtained his Ph.D. in Bioelectric Engineering from Amirkabir University of Technology. His doctoral research, titled “Modeling Parkinson Disease Using Chaotic Theory,” showcased his ability to apply complex mathematical frameworks to biomedical challenges, reflecting his interdisciplinary expertise.

Professional Experience

Dr. Sarbaz’s professional career began as a teaching assistant in the Department of Electrical Engineering at the University of Tabriz from 1998 to 2002. He continued in this role at Sharif University of Technology between 2002 and 2004, concurrently serving as a research assistant. From 2004 to 2006, he was a member of the academic staff at Sahand University of Technology. In 2005, he contributed as the Vice Scientific Committee Chair for the 12th Iranian Conference on Biomedical Engineering. Following his Ph.D., Dr. Sarbaz held teaching positions at Azad Islamic University and later returned to Sahand University. Since 2012, he has been a faculty member in the Department of Emerging Technologies at the University of Tabriz, where he continues to engage in teaching and research.

Research Interests

Dr. Sarbaz’s research interests are diverse and interdisciplinary, encompassing the modeling and simulation of biological systems, particularly neural diseases. He is proficient in system identification, the design of compensators and controllers, and the development of electronic circuits. His expertise extends to chaos theory, evolutionary and genetic algorithms, neural networks, and optimization techniques. Dr. Sarbaz is also deeply involved in electrophysiology and computational neuroscience, focusing on the design of rehabilitation systems. His work aims to bridge the gap between engineering and medicine, utilizing advanced computational methods to address complex biomedical challenges.

Research Skills

Dr. Sarbaz possesses a robust set of research skills that align with his interdisciplinary interests. He is adept at mathematical modeling and simulation of biological systems, employing system identification techniques to understand and predict system behaviors. His proficiency in designing electronic circuits and control systems is complemented by his application of chaos theory to model complex physiological phenomena. Dr. Sarbaz utilizes evolutionary and genetic algorithms for optimization problems and applies neural network methodologies to interpret complex data patterns. His skills in electrophysiology and computational neuroscience are instrumental in developing innovative rehabilitation systems and advancing the understanding of neural disorders.

Awards and Honors

Throughout his academic and professional career, Dr. Sarbaz has been recognized for his contributions to biomedical engineering and neuroscience. He consistently graduated at the top of his class during his academic pursuits, reflecting his dedication and excellence. His role as Vice Scientific Committee Chair at the 12th Iranian Conference on Biomedical Engineering in 2005 highlights his leadership within the scientific community. While specific awards and honors are not detailed in the provided information, Dr. Sarbaz’s extensive publication record and active participation in academic conferences underscore his respected status in his field.

Conclusion

Dr. Yashar Sarbaz exemplifies a commitment to advancing biomedical engineering through interdisciplinary research and education. His academic excellence, professional experience, and diverse research interests have positioned him as a leading figure in the modeling and treatment of neurodegenerative diseases. Dr. Sarbaz’s work not only contributes to the scientific understanding of complex neurological disorders but also holds promise for developing innovative therapeutic strategies. His dedication to integrating engineering principles with medical research continues to inspire and drive progress in the biomedical field.

Publication Top Notes

  1. A robust method for Parkinson’s disease diagnosis: Combining electroencephalography signal features with reconstructed phase space images

    • Author(s): Farnaz F. Garehdaghi, Yashar Y. Sarbaz
    • Year: 2025

  2. Cortical complexity alterations in motor subtypes of Parkinson’s disease: A surface-based morphometry analysis of fractal dimension

    • Author(s): Yousef Y. Dehghan, Yashar Y. Sarbaz
    • Year: 2024

  3. The influence of mental calculations on brain regions and heart rates

    • Author(s): Morteza M. Jafari Malali, Yashar Y. Sarbaz, Sepideh S. Zolfaghari, Armin A. Khodayarlou
    • Year: 2024
    • Citations: 1

  4. EEG-based classification of Alzheimer’s disease and frontotemporal dementia: a comprehensive analysis of discriminative features

    • Author(s): Mehran M. Rostamikia, Yashar Y. Sarbaz, Somayeh S. Makouei
    • Year: 2024
    • Citations: 2

  5. Extracting brain behavior change in patients with migraine by quantitative analysis of electroencephalogram signal of patients compared to healthy people

    • Author(s): Yashar Y. Sarbaz, Farnaz F. Garehdaghi, Saeed S. Meshgini
    • Year: 2024

 

Mariana Udo | Neuroscience | Best Researcher Award

Published on by World Science Awards

Dr. Mariana Udo | Neuroscience | Best Researcher Award

Postdoctoral Fellow at University of Texas Health, United States

Dr. Mariana Sayuri Berto Udo is a dedicated researcher with extensive expertise in neurotoxicology, neurodegenerative diseases, cognition impairment, and aging. Currently a Postdoctoral Fellow at the Department of Neurology at Louisiana State University Health Sciences Center (LSU Health Shreveport), her work focuses on understanding vascular dementia and related pathways. Dr. Udo’s career spans multiple countries, including Brazil, Japan, and the United States, reflecting her global research perspective. She has secured prestigious funding from organizations such as the American Heart Association and has earned recognition for her scientific contributions. Dr. Udo has also served in academic mentorship, professional service, and research collaborations, making her a well-rounded scientist in her field.

Professional Profile

Education

Dr. Udo earned her Ph.D. (2013–2018) and MSc. (2010–2012) in Clinical and Toxicological Analysis from the University of São Paulo, Brazil, after completing her B.S. in Pharmaceutical Science at Methodist University of Piracicaba (2002–2006). She also obtained a certification in Clinical and Analytical Toxicology from the University of Campinas in 2007. Currently, she is a Postdoctoral Fellow at LSU Health Shreveport (2021–present), advancing her expertise in neurology. Her multidisciplinary education underlines her comprehensive understanding of pharmaceutical science, toxicology, and neurobiology.

Professional Experience

Dr. Udo has held various academic and research roles. As a Research Assistant at Asahikawa Medical University in Japan (2019–2021), she contributed to projects on neurophysiology and pharmacology. From 2013 to 2018, she was a lecturer at the Psychoanalytic Research Center, São Paulo, Brazil, where she taught neurophysiology and pharmacology. Additionally, she has contributed to scientific committees and evaluation boards, reflecting her dedication to advancing education and research.

Research Interests

Dr. Udo’s research interests encompass neurotoxicology, neurodegenerative diseases, cognition impairment, and aging. She is particularly focused on the organization and derangement of the microvasculature and the role of lipid rafts in neurodegenerative processes. Her work aims to elucidate mechanisms that contribute to vascular dementia, with an emphasis on improving understanding and treatment of age-related neurological disorders.

Research Skills

Dr. Udo is proficient in advanced research methodologies, including molecular and cellular biology, neurophysiological studies, and toxicological analysis. She has experience with preclinical models, pharmacological assessments, and data analysis related to neurodegeneration and cognition. Her ability to design and execute complex experiments, coupled with her analytical skills, has been instrumental in advancing her research objectives.

Awards and Honors

Dr. Udo has received numerous accolades for her work, including the Best Oral Presentation Award at the XXIV Benjamin Eurico Malucelli Scientific Meeting in 2015. She has also secured prestigious funding, such as the American Heart Association Postdoctoral Fellowship (2024–2025) and the Malcolm Feist Cardiovascular Research Fellowship (2023–2024). These recognitions reflect her significant contributions to the field of neurology and toxicology.

Conclusion

Dr. Mariana Sayuri Berto Udo is an excellent candidate for the Best Researcher Award due to her diverse academic background, international research experience, substantial funding achievements, and focus on impactful areas of neurology and toxicology. To further enhance her application, she could focus on increasing her publication record in high-impact journals and expanding global collaborations. Overall, her research and contributions make her a strong contender for this prestigious recognition.

Publication Top Notes

  1. Prenatal exposure to a low fipronil dose disturbs maternal behavior and reflex development in rats
    Authors: MSB Udo, TM Sandini, TM Reis, MM Bernardi, HS Spinosa
    Journal: Neurotoxicology and Teratology
    Year: 2014
    Citations: 51
  2. Desenvolvimento e estudos preliminares de estabilidade de formulações fotoprotetoras contendo Granlux GAI-45 TS
    Authors: M Chorilli, MS Udo, ME Cavallini, GR Leonardi
    Journal: Revista de Ciências Farmacêuticas Básica e Aplicada
    Year: 2006
    Citations: 36
  3. Prenatal exposure to integerrimine N-oxide impaired the maternal care and the physical and behavioral development of offspring rats
    Authors: TM Sandini, MSB Udo, TM Reis-Silva, MM Bernardi, HS Spinosa
    Journal: International Journal of Developmental Neuroscience
    Year: 2014
    Citations: 22
  4. Prenatal exposure to fipronil disturbs maternal aggressive behavior in rats
    Authors: JZ Magalhães, MSB Udo, AM Sánchez-Sarmiento, MPN Carvalho, …
    Journal: Neurotoxicology and Teratology
    Year: 2015
    Citations: 20
  5. M1 and M3 muscarinic receptors may play a role in the neurotoxicity of anhydroecgonine methyl ester, a cocaine pyrolysis product
    Authors: RCT Garcia, LMM Dati, LH Torres, MAA da Silva, MSB Udo, FMF Abdalla, …
    Journal: Scientific Reports
    Year: 2015
    Citations: 17
  6. Senecio brasiliensis e alcaloides pirrolizidínicos: toxicidade em animais e na saúde humana
    Authors: TM Sandini, MSB Udo, H de Souza Spinosa
    Journal: Biotemas
    Year: 2013
    Citations: 16
  7. Prenatal exposure to integerrimine N-oxide enriched butanolic residue from Senecio brasiliensis affects behavior and striatal neurotransmitter levels of rats in adulthood
    Authors: TM Sandini, MSB Udo, TM Reis-Silva, D Sanches, MM Bernardi, JC Flório, …
    Journal: International Journal of Developmental Neuroscience
    Year: 2015
    Citations: 13
  8. Fipronil: uses, pharmacological and toxicological features
    Authors: JZ Magalhães, TM Sandini, MSB Udo, A Fukushima, H de Souza-Spinosa
    Journal: Revinter
    Year: 2018
    Citations: 12
  9. Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer’s disease
    Authors: GA Clemons, AC Silva, CH Acosta, MSB Udo, V Tesic, KM Rodgers, …
    Journal: Journal of Cellular Physiology
    Year: 2024
    Citations: 11
  10. Anhydroecgonine methyl ester, a cocaine pyrolysis product, contributes to cocaine-induced rat primary hippocampal neuronal death in a synergistic and time-dependent manner
    Authors: MSB Udo, MAA da Silva, S de Souza Prates, LF Dal’Jovem, …
    Journal: Archives of Toxicology
    Year: 2021
    Citations: 9